Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.450
-0.020 (-1.36%)
At close: Sep 26, 2025, 4:00 PM EDT
1.500
+0.050 (3.45%)
After-hours: Sep 26, 2025, 7:14 PM EDT
Zynex Market Cap
Zynex has a market cap or net worth of $43.93 million as of September 26, 2025. Its market cap has decreased by -82.62% in one year.
Market Cap
43.93M
Enterprise Value
98.85M
1-Year Change
-82.62%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since February 12, 2019, Zynex's market cap has decreased from $154.40M to $43.93M, a decrease of -71.55%. That is a compound annual growth rate of -17.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 43.90M | -82.79% |
| Dec 31, 2024 | 255.10M | -30.90% |
| Dec 29, 2023 | 369.20M | -29.14% |
| Dec 30, 2022 | 521.00M | 50.23% |
| Dec 31, 2021 | 346.80M | -25.83% |
| Dec 31, 2020 | 467.60M | 81.45% |
| Dec 31, 2019 | 257.70M | 66.90% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |